India's Navin Fluorine rises as Jefferies reiterates "buy" rating

Navin Fluorine International

17/06/2026 07:36

** Shares of Navin Fluorine International NAFL.NS rise nearly 2% to 7,447.5 rupees
** Jefferies reiterates stock rating at "buy", with PT at 8,700 rupees
** Says company's strong pipelines in contract manufacturing and cooling products, and participation in new molecules in spectral chemistry anchor its medium-term growth
** Believes that one of the company's molecules, which has been fast-tracked by the US FDA for Bayer's prostate cancer drug, could grow significantly by 2032
** Jefferies sees 19% potential upside for EBITDA over FY26-FY29
** Expects revenue CAGR at 20%-25% over the same period
** Stock rated "buy", on average, by 25 analysts; median PT at 7,542.5 rupees
** YTD, stock up 25.8%

(Reporting by Mridula Kumar in Bengaluru)
((Mridula.Kumar@thomsonreuters.com;))